Because SELENOF has a thioredoxin-like catalytic site, SELENOF is thought to either regulate UGGT activity or the redox state of UGGT substrates (32)
Some investigators have examined both peptides concurrently in tissue repair models, noting that their non-overlapping pathways may produce complementary downstream effects on vascularization and extracellular matrix remodeling
Neurology 96 , e1369e1382 (2021)
Risks, Regulatory Issues, and Safety Concerns Peptides may sound like an exciting shortcut for muscle maintenance, but they come with significant risks when they are unregulated or when used without medical supervision
While early research is promising, it is still an experimental compound with limited human data
The results were strong enough for Novo to greenlight a new dedicated Phase 3 program, and investors took notice